Unclassified
International Myeloma Foundation
STUDIO CITY, CA
Total revenue
$19.0M
Total expenses
$20.8M
Net assets
$10.3M
Grants received
$4.5M
241 grants
EIN
954296919
Tax year
2023
Mission
Dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
Programs
3 programs
Education and awareness - although it is the second most common blood cancer, multiple myeloma is still a relatively unknown disease. For many patients and their caregivers, it is at diagnosis when they first heard the word "myeloma". Imf recognizes the need for comprehensive education programs for both the patient and the physician to ensure that patients are diagnosed correctly and treated effectively. Our library of more than 100 publications for patients, caregivers and healthcare professionals, is available free of charge. Publications are updated annually and available in more than 19 international languages. The imf empowers patients and their caregivers to join healthcare providers as active decision-making partners, leading to the best possible quality of life for each individual myeloma patient. The imf produces comprehensive but 'user-friendly' information for the entire myeloma community. The imf's publications library includes an extensive catalog of booklets, tip cards, articles, webinars and teleconferences, blogs, digital media and interviews, all written, created, and produced by the imf with oversight by its scientific advisory committee. The imf library's broad scope includes information about myeloma treatment options, clinical trials, diversity, equity and quality of life considerations for patients and physicians.
Patient and family seminars: the imf's patient and family seminars present vital information about new treatments and clinical trials, provide time with myeloma specialists in intimate settings, and allow participants to share their personal experiences and support. Premier myeloma experts volunteer their time to the seminars, to empower patients and their families to make educated treatment choices tailored to their needs. In addition to patient and family seminars, the imf facilitates regional community workshops, which serve as condensed seminars in smaller cities to expand the reach of imf programs and up-to-date information on myeloma care, support and treatment to a wider audience at no charge.
International - the imf grows its network of health care professionals around the world. Key team members organize physician as well as patient meetings in order to provide education about the latest developments in the field of multiple myeloma.support groups - through a global community of voluntary support groups, the imf seeks to ensure that patients and families have local access to support and education. The imf currently supports over 300 support groups worldwide. The imf offers unequaled website creation and hosting for local support groups, and provided a unique opportunity for some support group leaders to attend the american society of hematology annual meeting. The 25th annual support group leaders summit took place with more than 90 leaders in attendance. Technology continues to be emphasized for support group leaders. The imf also continued to update its app specifically designed for support group leaders which offer meeting and education materials accessible to help build effective communicanurse - the imf nurse leadership board is a professional partnership representing nurse experts caring for myeloma patients at leading medical centers. Founded in november 2006, the nlb has proven to be invaluable to the myeloma community as a platform that bolsters nursing education, clinical care experience exchange, and patient knowledge and empowerment in an effort to optimize outcomes for patients with myeloma. This board of experienced myeloma nurses has made great strides in improving the nursing care and self-care of myeloma patients since its inception.clinical meetings - imf team members organize clinical meetings, bringing together the world's leading myeloma experts, to form a coalition that will work collaboratively on myeloma-related projects and avoid duplication of efforts and dilution of valuable resources. These coalitions promote excellence in clinical practice, research and education and cme-accredited medical education programs. This past year also included education to the community physician via online and live instruction.advocacy - the imf is dedicated to creating a global community that supports the wide-ranging needs of all affected by myeloma. The imf advocates on behalf of those affected by multiple myeloma for an increase in accessibility of high-quality diagnostics and treatments, for funding of myeloma-related research, and for an end to insurance coverage disparities for treatment. The imf includes the entire myeloma community in these efforts and continues to expand its commitment to empowering patients, families, and friends to advocate on behalf of patient rights.infoline - the imf's toll-free information telephone line provides life-saving and life-changing myeloma treatment and management support from compassionate, highly trained specialists. As new treatment options are gaining attention and use in multiple myeloma, answering questions about myeloma, its treatment, drug side effects, options for possible clinical trials other health concerns, and where to find local support is more important than ever.website - the imf website is the leading resource for myeloma-related content and the most complete source of answers from the many questions asked by those newly diagnosed to those managing myeloma for many years. The website considers patients, caregivers, family members, and healthcare professionals. Information is available in multiple languages and focus is on the imf's research, education, support and advocacy initiatives. Imf launched myelo, the imf website's chatbox or chat feature designed to provide general information and support related to multiple myeloma. It is not intended to replace professional medical advice, diagnosis, or treatment from qualified healthcare providers. See imf website for further information. Myeloma today - myeloma today is a quarterly newsletter and the go-to resource for the myeloma community to learn about the latest advances in myeloma treatment, research and quality of life issues. It is provided free of charge.informational mailings - the infopack is made up of a selection of the imf's publications and is designed to provide newly diagnosed patients and their families with a complete understanding of the disease and care. The info pack contains informative materials free of charge in 19 languages.
Financials
FY 2023
Revenue
Expenses
People
24 listed
YELAK BIRU
CEO, PRESIDENT, DIRECTOR
$430K
40 hrs/wk
JENNIFER SCARNE
CHIEF FINANCIAL OFFICER
$303K
40 hrs/wk
CHARLES NEWMAN
DIRECTOR
—
1 hrs/wk
MATTHEW ROBINSON
DIRECTOR
—
1 hrs/wk
DR VINCENT RAJKUMAR
CHAIRMAN
—
40 hrs/wk
E MICHAEL SCOTT
DIRECTOR
—
1 hrs/wk
SANJAY SINGH
DIRECTOR
—
1 hrs/wk
JOHN O'DWYER
DIRECTOR
—
1 hrs/wk
POORNIMA PARAMESWARAN
DIRECTOR
—
1 hrs/wk
CHRISTINE BATTISTINI
DIRECTOR
—
1 hrs/wk
LORAINE BOYLE
DIRECTOR
—
1 hrs/wk
GEORGE T HAYUM
DIRECTOR
—
1 hrs/wk
MARTINE ELIAS
DIRECTOR
—
1 hrs/wk
JASON KATZ
DIRECTOR
—
1 hrs/wk
BENSON KLEIN
DIRECTOR
—
1 hrs/wk
ANDREW KUZNESKI III
DIRECTOR
—
1 hrs/wk
DR HEINZ LUDWIG
DIRECTOR
—
1 hrs/wk
JOSEPH MIKHAEL
CHIEF MEDICAL OFFICER
$460K
40 hrs/wk
DIANE MORAN
SENIOR VICE PRESIDENT - BUSINESS RELATIONSHIP MANA
$433K
40 hrs/wk
DR BRIAN DURIE
CHIEF SCIENTIFIC OFFICER-FORMER DIR
$430K
40 hrs/wk
SUSAN DURIE
DIRECTOR OF GLOBAL PATIENT EMPOWERMENT-FORMER DIR
$363K
40 hrs/wk
LISA PAIK
EXECUTIVE VICE PRESIDENT - RESEARCH & OPERATIONS
$275K
40 hrs/wk
PETER ANTON
VICE PRESIDENT, MARKETING
$226K
40 hrs/wk
ROBIN TUOHY
VICE PRESIDENT, PATIENT SUPPORT
$180K
40 hrs/wk
Independent contractors
MIMI CHOON-QUINONES
INTERNATIONAL ADVOCACY, ACCESS, POLICY,
DAN NAVID
INTERNATIONAL GLOBAL STRATEGY
MICHELLE FABER
GRANT SUPPORT AND PROGRAM MANAGEMENT
Grants received
Showing 200 of 241
Funded by
$4.5M from 98 funders · 241 grants · 2017–2024
$1.9M · 7 grants · 2020–2023
$412K · 8 grants · 2017–2023
$329K · 7 grants · 2018–2024
$200K · 4 grants · 2020–2023
$200K · 7 grants · 2017–2023
$195K · 6 grants · 2019–2024
$160K · 3 grants · 2022–2024
$110K · 6 grants · 2017–2023